Oruka Therapeutics, Inc.
ORKA
Revenue
0.00
0.000.00%
12 Months ChangeAssets
33.84M
▼-2.86M▼-7.80%
3 Months ChangeLiabilities
1.27M
▼-310.00k▼-19.61%
3 Months ChangeFree Cash Flow
-4.30M
▲931.00k▲17.80%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-04
Form 8-K
ID: 0001213900-24-085543
2024-09-13
Form 8-K
ID: 0001213900-24-078549
2024-09-05
Form 8-K
ID: 0001213900-24-076184
2024-08-27
Form 8-K
ID: 0001213900-24-072683
2024-08-23
Form 8-K
ID: 0001213900-24-072251
2024-08-16
Form 8-K
ID: 0001213900-24-070263
2024-08-15
Form 8-K
ID: 0001213900-24-069662
2024-08-01
Form 8-K
ID: 0000950170-24-089329
2024-08-01
Form 10-Q
ID: 0000950170-24-089246
2024-07-09
Form 8-K
ID: 0001213900-24-060156